Radiation Dosimetry in Theranostics: A Review
Journal of Nuclear Medicine Technology · 2025-12 · 53 (Supplement 1) · 38S-48S
DOI: 10.2967/jnmt.125.270852 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine Technology, online erschienen am 04.12.2025. Verfasst von Pat Zanzonico. Beteiligte Einrichtung: Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York zanzonip@mskcc.org. Hauptthemen laut MEDLINE: Radiometry, Precision Medicine, Theranostic Nanomedicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Theranostics refers to the combination of therapy and diagnostics in a single clinical entity or approach. Theranostics is particularly adaptable to radiopharmaceutical therapy (RPT) based on the unique ability to scintigraphically image radiopharmaceuticals in vivo and thereby noninvasively measure their time-dependent activities in and among target lesions and normal organs. Theranostics with personalized RPT, based on the maximum tolerated dose to the therapy-limiting tissue or the prescribed dose to the target tissue, offers the important advantages of lower toxicity or greater efficacy compared with fixed-administered-activity RPT but requires rather time-consuming, technically challenging patient measurements and analyses. Importantly, however, the perceived obstacles to dosimetry-based RPT have been or are being largely overcome. Further, the currently available dose-response data, though still rather limited, indicate that patient-specific dosimetry may help optimize RPT by minimizing toxicity or maximizing efficacy. Additional dose-response data from prospective multicenter trials are still required to definitively establish the value of patient-specific dosimetry in RPT. Such trials will require standardization of calibration procedures, acquisition protocols, and reconstruction methods among participating institutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York zanzonip@mskcc.org.
Zitieren
APA
Zanzonico, P. (2025). Radiation Dosimetry in Theranostics: A Review. Journal of Nuclear Medicine Technology, 53(Supplement 1), 38S-48S. https://doi.org/10.2967/jnmt.125.270852
Vancouver
Zanzonico P. Radiation Dosimetry in Theranostics: A Review. Journal of Nuclear Medicine Technology. 2025;53(Supplement 1):38S-48S. doi:10.2967/jnmt.125.270852
BibTeX
@article{Zanzonico2025,
author = {Zanzonico, Pat},
title = {Radiation Dosimetry in Theranostics: A Review},
journal = {Journal of Nuclear Medicine Technology},
year = {2025},
volume = {53},
number = {Supplement 1},
pages = {38S--48S},
doi = {10.2967/jnmt.125.270852}
}
EUVIMED